Frederick Lowery
Health care solutions provider Henry Schein Inc. (Nasdaq: HSIC) has named a new CEO.
Frederick M. Lowery takes over the position on March 2 and will join the board of directors as well. Lowery replaces Stanley M. Bergman, who has been Henry Schein’s CEO for 35 years. Bergman will continue as the company’s chairman of the board.
“Mr. Lowery brings more than two decades of health care expertise to Henry Schein, with a strong track record of scaling complex businesses to drive significant growth and sustained value creation,” the company said in a Jan. 12 announcement. “Most recently, he served as executive vice president and president, Laboratory Products and BioProduction, at Thermo Fisher Scientific, leading the Fisher Scientific distribution channel’s above-market performance. His experience growing distribution and owned product businesses — including manufacturing, R&D, marketing, and sales functions — closely aligns with Henry Schein’s business model, positioning him well to guide the company’s next phase of growth and continued execution of its BOLD+1 strategic plan.”
While Henry Schein is best known for its health care solutions for office-based dental and medical practitioners, the company has also been focusing on the home medical equipment segment recently. In January 2025, Henry Schein acquired Acentus, a continuous glucose monitor (CGM) provider. That transaction followed the 2021 acquisition of Prism Medical Products, and the 2023 acquisitions of Shield Healthcare, and Mini Pharmacy.
“I am honored to join Henry Schein at such a pivotal moment,” Lowery said in the announcement. “This is an organization with immense potential to impact clinicians and patients, given its remarkable reputation for innovation, customer service, and partnership. I look forward to working with Team Schein to build on the strong foundation established by Stan while accelerating value creation.”
